← All trials
NCT04654078
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 18, 2021
- Primary completion
- Feb 5, 2021
- Completion date
- Feb 15, 2021
- First posted
- Dec 4, 2020
- Last posted
- Mar 29, 2021
- Enrollment
- 48
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Inno.NLead sponsor
- Chonbuk National UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.